{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:28:51Z","timestamp":1784993331640,"version":"3.55.0"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T00:00:00Z","timestamp":1438646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T00:00:00Z","timestamp":1438646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015303","name":"Otsuka Pharmaceutical Development & Commercialization","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015303","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Methods Psychiatr. Res."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1002\/mpr.1483","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T10:07:15Z","timestamp":1438682835000},"page":"101-111","source":"Crossref","is-referenced-by-count":22,"title":["Defining the minimal clinically important difference (MCID) of the Heinrichs-carpenter quality of life scale (QLS)"],"prefix":"10.1002","volume":"25","author":[{"given":"Bruno","family":"Falissard","sequence":"first","affiliation":[{"name":"INSERM U669; Universit\u00e9 Paris-Sud and Universit\u00e9 Paris-Descartes, APHP; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Sapin","sequence":"additional","affiliation":[{"name":"Global Analytics; Lundbeck SAS; Issy-les-Moulineaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Loze","sequence":"additional","affiliation":[{"name":"Otsuka Pharmaceutical Europe Ltd; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wally","family":"Landsberg","sequence":"additional","affiliation":[{"name":"Otsuka Pharmaceutical Europe Ltd; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Hansen","sequence":"additional","affiliation":[{"name":"Global Health Economics and Epidemiology; Lundbeck SAS; Issy-les-Moulineaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,4]]},"reference":[{"key":"10.1002\/mpr.1483-BIB0001|mpr1483-cit-0001","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2147\/IJGM.S29052","article-title":"Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open label treatment of schizophrenia: indirect, exploratory comparisons","volume":"5","author":"Ascher-Svanum","year":"2012","journal-title":"International Journal of General Medicine"},{"key":"10.1002\/mpr.1483-BIB0002|mpr1483-cit-0002","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s11136-012-0335-z","volume":"22","author":"Ascher-Svanum","year":"2013","journal-title":"Quality of Life Research"},{"key":"10.1002\/mpr.1483-BIB0003|mpr1483-cit-0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00019053-200826020-00005","article-title":"The burden of schizophrenia on caregivers: a review","volume":"26","author":"Awad","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1002\/mpr.1483-BIB0004|mpr1483-cit-0004","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-244X-13-15","article-title":"Quality of life is predictive of relapse in schizophrenia","volume":"13","author":"Boyer","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1002\/mpr.1483-BIB0005|mpr1483-cit-0005","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1477-7525-4-69","article-title":"How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure","volume":"27","author":"Brozek","year":"2006","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/mpr.1483-BIB0006|mpr1483-cit-0006","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000017201","article-title":"Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration","volume":"10","author":"Burback","year":"1999","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/mpr.1483-BIB0007|mpr1483-cit-0007","first-page":"336","article-title":"The Quality of Life Scale (QLS) for schizophrenia: assessment of responsiveness to clinical change","volume":"9","author":"Bushnell","year":"2000","journal-title":"Quality of Life Research"},{"key":"10.1002\/mpr.1483-BIB0008|mpr1483-cit-0008","doi-asserted-by":"crossref","first-page":"s28","DOI":"10.1192\/bjp.177.39.s28","article-title":"Client Socio-demographic and Service Receipt Inventory - European version: development of an instrument for international research. EPSILON Study 5. European psychiatric services: inputs linked to outcome domains and needs","volume":"177","author":"Chisholm","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/mpr.1483-BIB0009|mpr1483-cit-0009","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","article-title":"Understanding the minimum clinically important difference: a review of concepts and methods","volume":"7","author":"Copay","year":"2007","journal-title":"Spine Journal"},{"key":"10.1002\/mpr.1483-BIB0010|mpr1483-cit-0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/oxfordjournals.schbul.a006869","article-title":"Detecting improvement in quality of life and symptomatology in schizophrenia","volume":"27","author":"Cramer","year":"2001","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/mpr.1483-BIB0011|mpr1483-cit-0011","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.schres.2006.06.002","article-title":"Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes","volume":"86","author":"Dunayevitch","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1002\/mpr.1483-BIB0012|mpr1483-cit-0012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol: a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1002\/mpr.1483-BIB0013|mpr1483-cit-0013","doi-asserted-by":"publisher","DOI":"10.1002\/sim.941","volume-title":"Quality of Life: Assessment, Analysis and Interpretation","author":"Fayers","year":"2000"},{"key":"10.1002\/mpr.1483-BIB0014|mpr1483-cit-0014","volume-title":"ECDEU Assessment Manual for Psychopharmacology Revised","author":"Guy","year":"1976"},{"key":"10.1002\/mpr.1483-BIB0015|mpr1483-cit-0015","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/mpr.1483-BIB0016|mpr1483-cit-0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/mpr.1483-BIB0017|mpr1483-cit-0017","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost-Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/mpr.1483-BIB0018|mpr1483-cit-0018","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","article-title":"Determining a minimal important change in a disease-specific quality of life questionnaire","volume":"47","author":"Juniper","year":"1994","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/mpr.1483-BIB0019|mpr1483-cit-0019","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.eurpsy.2007.03.002","article-title":"A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study","volume":"22","author":"Kerwin","year":"2007","journal-title":"European Psychiatry"},{"key":"10.1002\/mpr.1483-BIB0020|mpr1483-cit-0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/oby.2001.13","article-title":"Development of a brief measure to assess quality of life in obesity","volume":"9","author":"Kolotkin","year":"2001","journal-title":"Obesity Research"},{"key":"10.1002\/mpr.1483-BIB0021|mpr1483-cit-0021","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1007\/s00586-009-1070-1","article-title":"What is an acceptable outcome of treatment before it begins? Methodological considerations and implications for patients with chronic low back pain","volume":"18","author":"Lauridsen","year":"2009","journal-title":"European Spine Journal"},{"key":"10.1002\/mpr.1483-BIB0022|mpr1483-cit-0022","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00449427","article-title":"Convergent validation of quality of life assessments for persons with severe mental illnesses","volume":"2","author":"Lehman","year":"1993","journal-title":"Quality of Life Research"},{"key":"10.1002\/mpr.1483-BIB0023|mpr1483-cit-0023","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1176\/appi.ps.54.11.1499","article-title":"Integrated treatment of schizophrenia","volume":"54","author":"Lenroot","year":"2003","journal-title":"Psychiatric Services"},{"key":"10.1002\/mpr.1483-BIB0024|mpr1483-cit-0024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"Journal of Sex and Marital Therapy"},{"key":"10.1002\/mpr.1483-BIB0025|mpr1483-cit-0025","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1001\/jama.2014.13128","article-title":"Minimal clinically important difference: defining what really matters to patients","volume":"312","author":"McGlothlin","year":"2014","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1002\/mpr.1483-BIB0026|mpr1483-cit-0026","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/COPD-200050660","article-title":"US regulatory perspective on the minimal clinically important difference in chronic obstructive pulmonary disease","volume":"2","author":"Meyer","year":"2005","journal-title":"COPD: Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/mpr.1483-BIB0027|mpr1483-cit-0027","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.berh.2005.03.003","article-title":"Clinically important outcomes in low back pain","volume":"19","author":"Ostelo","year":"2005","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"10.1002\/mpr.1483-BIB0028|mpr1483-cit-0028","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.hrtlng.2007.09.007","article-title":"Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation","volume":"37","author":"Parshall","year":"2008","journal-title":"Heart & Lung"},{"key":"10.1002\/mpr.1483-BIB0029|mpr1483-cit-0029","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4088\/JCP.v67n0910","article-title":"The relationship between quality of life and clinical efficacy from a randomised trial comparing olanzapine and ziprasidone","volume":"67","author":"Philipps","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/mpr.1483-BIB0030|mpr1483-cit-0030","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jclinepi.2007.05.011","article-title":"Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient reported outcomes measures","volume":"61","author":"Rejas","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/mpr.1483-BIB0031|mpr1483-cit-0031","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3899\/jrheum.130609","article-title":"Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: a multicenter study","volume":"41","author":"Singh","year":"2014","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/mpr.1483-BIB0032|mpr1483-cit-0032","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1378\/chest.126.1.81","article-title":"The Veterans Short Form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD","volume":"126","author":"Sprenkle","year":"2004","journal-title":"Chest"},{"key":"10.1002\/mpr.1483-BIB0033|mpr1483-cit-0033","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1176\/appi.ajp.164.3.428","article-title":"Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study","volume":"164","author":"Swartz","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/mpr.1483-BIB0034|mpr1483-cit-0034","doi-asserted-by":"crossref","first-page":"211-","DOI":"10.1016\/j.psychres.2005.05.006","article-title":"Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder","volume":"136","author":"Tandon","year":"2005","journal-title":"Psychiatry Research"},{"key":"10.1002\/mpr.1483-BIB0035|mpr1483-cit-0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2005.12.857","article-title":"A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial with Aripiprazole (BETA)","volume":"84","author":"Tandon","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1002\/mpr.1483-BIB0036|mpr1483-cit-0036","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jclinepi.2009.01.024","article-title":"The minimal detectable change cannot reliably replace the minimal important difference","volume":"63","author":"Turner","year":"2010","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/mpr.1483-BIB0037|mpr1483-cit-0037","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eurpsy.2011.10.002","article-title":"In patients with schizophrenia, symptoms improvement can be uncorrelated with quality of life improvement","volume":"28","author":"Wilson-d'Almeida","year":"2013","journal-title":"European Psychiatry"},{"key":"10.1002\/mpr.1483-BIB0038|mpr1483-cit-0038","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1185\/03007995.2012.657300","article-title":"Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia","volume":"28","author":"Witte","year":"2012","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/mpr.1483-BIB0039|mpr1483-cit-0039","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1081\/BIP-120028508","article-title":"Minimal important difference thresholds and the standard error of measurement: is there a connection?","volume":"14","author":"Wyrwich","year":"2004","journal-title":"Journal of Biopharmaceutical Statistics"},{"key":"10.1002\/mpr.1483-BIB0040|mpr1483-cit-0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0895-4356(99)00071-2","article-title":"Further evidence supporting a SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life","volume":"52","author":"Wyrwich","year":"1999","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/mpr.1483-BIB0041|mpr1483-cit-0041","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/annonc\/mdl065","article-title":"Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma","volume":"17","author":"Yeo","year":"2006","journal-title":"Annals of Oncology"}],"container-title":["International Journal of Methods in Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpr.1483","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpr.1483","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/mpr.1483\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T15:01:54Z","timestamp":1625410914000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpr.1483"}},"subtitle":["MCID for QLS"],"short-title":[],"issued":{"date-parts":[[2015,8,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1002\/mpr.1483","archive":["Portico"],"relation":{},"ISSN":["1049-8931"],"issn-type":[{"value":"1049-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,4]]}}}